Pub Date : 2025-02-18eCollection Date: 2025-01-01DOI: 10.5281/zenodo.14886922
Moses Ikegbunam, Abone Harrison, Chukwudi Egbuche, Nwasolu Obidi, Judith Mbamalu, Enyi Emmanuel, Offojebe Kosisochukwu, Mercy Ezeunala, Nzeukwu Chibumma, Ifeyinwa Onochie-Igbinedion, Joy Igwe, Joy Nnanna, Dorothy Ezeagwuna, Vincent Duru, Frances Nworji, Charles Esimone
Introduction: The genetic diversity of Plasmodium falciparum correlates with its pathogenicity, therefore design of evidence-based intervention strategies to eradicate malaria requires genetic diversity surveillance. This study characterised the allelic frequencies and genetic diversity of P. falciparum parasites isolated from Awka, Nigeria.
Materials and methods: Genomic DNA was extracted from 177 P. falciparum isolates and the polymorphic regions of the msp2 and glurp genes were genotyped by nested polymerase chain reaction (PCR).
Results: Two msp2 alleles (3D7 and FC27) were analysed. The 3D7 (93.55%) msp2 allelic family was predominant in msp2 positivie isolates. Polyclonal msp2 infection was observed in 24 (38.71%) isolates. Twenty-one distinct msp2 alleles were detected, with fragment sizes ranging from 200 bp to 1200 bp. The 300 bp allelic fragment (26.83%) was predominant for the 3D7 allele, while the 400 bp allelic fragment (29.54%) was predominant for the FC27 allele. The multiplicity of infection (MoI) in msp2 was 2.03, and the expected Heterozygosity (He) was 0.34. Sixty-nine isolates (38.98%) were positive for the RII repeat region of the glurp gene. For the glurp gene, nine alleles were detected for fragment sizes ranging from 200 bp to 1150 bp, and the most prevalent allelic fragment was 200 bp (19%). The MoI and He for the glurp gene were 0.45 and 0.98, respectively.
Conclusions: The high level of polyclonal infections with P. falciparum parasites observed in this study indicates extensive genetic diversity in the study area. The data provide important baseline information that can be implemented in developing malaria control strategies and elimination in the study area and Nigeria.
{"title":"Allelic frequency of <i>msp</i>2 and <i>glurp</i> genes in <i>Plasmodium falciparum</i> isolates from Awka, Anambra, Nigeria.","authors":"Moses Ikegbunam, Abone Harrison, Chukwudi Egbuche, Nwasolu Obidi, Judith Mbamalu, Enyi Emmanuel, Offojebe Kosisochukwu, Mercy Ezeunala, Nzeukwu Chibumma, Ifeyinwa Onochie-Igbinedion, Joy Igwe, Joy Nnanna, Dorothy Ezeagwuna, Vincent Duru, Frances Nworji, Charles Esimone","doi":"10.5281/zenodo.14886922","DOIUrl":"10.5281/zenodo.14886922","url":null,"abstract":"<p><strong>Introduction: </strong>The genetic diversity of <i>Plasmodium falciparum</i> correlates with its pathogenicity, therefore design of evidence-based intervention strategies to eradicate malaria requires genetic diversity surveillance. This study characterised the allelic frequencies and genetic diversity of <i>P. falciparum</i> parasites isolated from Awka, Nigeria.</p><p><strong>Materials and methods: </strong>Genomic DNA was extracted from 177 <i>P. falciparum</i> isolates and the polymorphic regions of the <i>msp2</i> and <i>glurp</i> genes were genotyped by nested polymerase chain reaction (PCR).</p><p><strong>Results: </strong>Two <i>msp2</i> alleles (3D7 and FC27) were analysed. The 3D7 (93.55%) <i>msp2</i> allelic family was predominant in <i>msp2</i> positivie isolates. Polyclonal <i>msp2</i> infection was observed in 24 (38.71%) isolates. Twenty-one distinct <i>msp2</i> alleles were detected, with fragment sizes ranging from 200 bp to 1200 bp. The 300 bp allelic fragment (26.83%) was predominant for the 3D7 allele, while the 400 bp allelic fragment (29.54%) was predominant for the FC27 allele. The multiplicity of infection (MoI) in <i>msp2</i> was 2.03, and the expected Heterozygosity (He) was 0.34. Sixty-nine isolates (38.98%) were positive for the RII repeat region of the <i>glurp</i> gene. For the <i>glurp</i> gene, nine alleles were detected for fragment sizes ranging from 200 bp to 1150 bp, and the most prevalent allelic fragment was 200 bp (19%). The MoI and He for the <i>glurp</i> gene were 0.45 and 0.98, respectively.</p><p><strong>Conclusions: </strong>The high level of polyclonal infections with <i>P. falciparum</i> parasites observed in this study indicates extensive genetic diversity in the study area. The data provide important baseline information that can be implemented in developing malaria control strategies and elimination in the study area and Nigeria.</p>","PeriodicalId":74100,"journal":{"name":"MalariaWorld journal","volume":"16 ","pages":"4"},"PeriodicalIF":0.0,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892418/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143598443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
For malaria control to be successful, experience has shown that success is more likely where all involved feel the attempt must not be allowed to fail, and that success can be the only acceptable outcome. Importantly, all those at the top must have such commitment, and, in particular, this should also include the funder, the source of finance of the attempt. That would be malaria control treated as a priority. If not treated as such, experience has shown the outcome of such attempts to be disappointing.
{"title":"Making malaria control a priority: a lesson for today's malaria community.","authors":"Anton Alexander","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>For malaria control to be successful, experience has shown that success is more likely where all involved feel the attempt must not be allowed to fail, and that success can be the only acceptable outcome. Importantly, all those at the top must have such commitment, and, in particular, this should also include the funder, the source of finance of the attempt. That would be malaria control treated as a priority. If not treated as such, experience has shown the outcome of such attempts to be disappointing.</p>","PeriodicalId":74100,"journal":{"name":"MalariaWorld journal","volume":"16 ","pages":"2"},"PeriodicalIF":0.0,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11770363/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143054461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-06eCollection Date: 2025-01-01DOI: 10.5281/zenodo.14604138
Oléfongo Dagnogo, Ako A B Ako, Dougba N Dago, Kouamé B A Kouman, N'golo D Coulibaly, Kouakou B Bla, Offianan A Touré, Allico J Djaman
<p><strong>Background: </strong><i>Plasmodium falciparum</i> has developed resistance to almost all the antimalarial drugs currently in use. This resistance has been and remains one of the greatest threats to the control and elimination of malaria. The use of molecular markers of resistance to monitor the emergence and spread of antimalarial drug-resistant parasite strains has proved highly effective. The aim of this study was to analyse the polymorphism of the <i>pfcrt</i>, <i>pfdhfr-ts</i> and <i>pfK13 propeller</i> genes for resistance in <i>P. falciparum</i> to chloroquine (CQ), pyrimethamine and artemisinin-based combination therapies (ACTs) in three sites in southern Côte d'Ivoire.</p><p><strong>Methodology: </strong>Blood samples were collected in Anonkoua-kouté, Port-Bouët, and Ayamé from 94 patients with microscopically confirmed uncomplicated <i>P. falciparum</i> malaria. These patients, aged over 2 years, gave their informed consent prior to blood sampling. <i>P. falciparum</i> genomic DNA extracted from these samples was amplified by nested PCR using primers specific to the <i>pfcrt</i>, <i>pfdhfr-ts</i> and <i>Pfk13 propeller</i> genes. The amplification products were sequenced using the Sanger method. After sequencing, the prevalence of <i>pfcrt</i> (M74I, N75E, K76T), <i>pfdhfr</i> (N51I, C59R, S108N) and <i>pfk13 propeller</i> (Y493H, R539T, I543T, C580Y, M476I and R561H) mutations confirmed to be involved in <i>P. falciparum</i> resistance to CQ, pyrimethamine and ACTs, respectively was determined. Data were analysed using R statistical software, version 3.2.2.</p><p><strong>Results: </strong>For all three study sites, 93 (93/94, i.e. 98.94%), 86 (86/94, i.e. 94.49%) and 74 (74/94, i.e. 78.72%) DNA fragments from patient isolates were successfully amplified for the <i>Pfk13 propeller</i>, <i>pfdhfr-ts</i> and <i>pfcrt</i> genes, respectively. Of the successfully amplified fragments, 93 (93/93, i.e. 100%), 81 (81/86, i.e. 94.18%) and 64 (64/74, i.e. 86.48%) were successfully sequenced for the <i>pfk13 propeller</i>, <i>pfdhfr-ts</i> and <i>pfcrt</i> genes, respectively. Sequence analysis indicated that S108N mutations in the <i>pfdhfr</i> gene and K76T mutations in the <i>pfcrt</i> gene were observed in 74.07% (60/81) and 15.62% (10/64) respectively. Analysis of the <i>k13 propeller</i> gene also showed a predominance of the YRICMR allelic form representing the sensitive haplotype (72/93, i.e. 78.49%).</p><p><strong>Conclusions: </strong>More than a decade after the abandonment of the use of CQ and the adoption of sulfadoxinepyrimethamine (SP) as intermittent preventive treatment (IPT) for pregnant women, the prevalence of alleles associated with CQ chemoresistance, represented by the K76T mutation in the <i>pfcrt</i> gene, fell, while that of alleles associated with pyrimethamine chemoresistance, represented by the S108N mutation in the <i>pfdhfr-ts</i> gene, increased in Anonkoua-Kouté, Port-Bouët and Ayamé. No mutations in muta
{"title":"Prevalence and genetic diversity of polymorphisms in <i>pfcrt</i>, <i>pfdhfr-ts</i> and <i>pfk13 propeller</i> genes of <i>Plasmodium falciparum</i> in southern Côte d'Ivoire.","authors":"Oléfongo Dagnogo, Ako A B Ako, Dougba N Dago, Kouamé B A Kouman, N'golo D Coulibaly, Kouakou B Bla, Offianan A Touré, Allico J Djaman","doi":"10.5281/zenodo.14604138","DOIUrl":"10.5281/zenodo.14604138","url":null,"abstract":"<p><strong>Background: </strong><i>Plasmodium falciparum</i> has developed resistance to almost all the antimalarial drugs currently in use. This resistance has been and remains one of the greatest threats to the control and elimination of malaria. The use of molecular markers of resistance to monitor the emergence and spread of antimalarial drug-resistant parasite strains has proved highly effective. The aim of this study was to analyse the polymorphism of the <i>pfcrt</i>, <i>pfdhfr-ts</i> and <i>pfK13 propeller</i> genes for resistance in <i>P. falciparum</i> to chloroquine (CQ), pyrimethamine and artemisinin-based combination therapies (ACTs) in three sites in southern Côte d'Ivoire.</p><p><strong>Methodology: </strong>Blood samples were collected in Anonkoua-kouté, Port-Bouët, and Ayamé from 94 patients with microscopically confirmed uncomplicated <i>P. falciparum</i> malaria. These patients, aged over 2 years, gave their informed consent prior to blood sampling. <i>P. falciparum</i> genomic DNA extracted from these samples was amplified by nested PCR using primers specific to the <i>pfcrt</i>, <i>pfdhfr-ts</i> and <i>Pfk13 propeller</i> genes. The amplification products were sequenced using the Sanger method. After sequencing, the prevalence of <i>pfcrt</i> (M74I, N75E, K76T), <i>pfdhfr</i> (N51I, C59R, S108N) and <i>pfk13 propeller</i> (Y493H, R539T, I543T, C580Y, M476I and R561H) mutations confirmed to be involved in <i>P. falciparum</i> resistance to CQ, pyrimethamine and ACTs, respectively was determined. Data were analysed using R statistical software, version 3.2.2.</p><p><strong>Results: </strong>For all three study sites, 93 (93/94, i.e. 98.94%), 86 (86/94, i.e. 94.49%) and 74 (74/94, i.e. 78.72%) DNA fragments from patient isolates were successfully amplified for the <i>Pfk13 propeller</i>, <i>pfdhfr-ts</i> and <i>pfcrt</i> genes, respectively. Of the successfully amplified fragments, 93 (93/93, i.e. 100%), 81 (81/86, i.e. 94.18%) and 64 (64/74, i.e. 86.48%) were successfully sequenced for the <i>pfk13 propeller</i>, <i>pfdhfr-ts</i> and <i>pfcrt</i> genes, respectively. Sequence analysis indicated that S108N mutations in the <i>pfdhfr</i> gene and K76T mutations in the <i>pfcrt</i> gene were observed in 74.07% (60/81) and 15.62% (10/64) respectively. Analysis of the <i>k13 propeller</i> gene also showed a predominance of the YRICMR allelic form representing the sensitive haplotype (72/93, i.e. 78.49%).</p><p><strong>Conclusions: </strong>More than a decade after the abandonment of the use of CQ and the adoption of sulfadoxinepyrimethamine (SP) as intermittent preventive treatment (IPT) for pregnant women, the prevalence of alleles associated with CQ chemoresistance, represented by the K76T mutation in the <i>pfcrt</i> gene, fell, while that of alleles associated with pyrimethamine chemoresistance, represented by the S108N mutation in the <i>pfdhfr-ts</i> gene, increased in Anonkoua-Kouté, Port-Bouët and Ayamé. No mutations in muta","PeriodicalId":74100,"journal":{"name":"MalariaWorld journal","volume":"16 ","pages":"1"},"PeriodicalIF":0.0,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11716317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142973852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-04eCollection Date: 2024-01-01DOI: 10.5281/zenodo.14278016
Silas Majambere
In the aftermath of the 2015 political crisis in Burundi, a humanitarian organisation, Maison Shalom, fled the country to Rwanda with tens of thousands of Burundians. In an attempt to assist their compatriots, a group of Burundians in the diaspora created the Académie Ubuntu and teamed with Maison Shalom to give online classes to the refugees. With courage and determination and despite the conditions in the refugee camp and the language barrier, 17 refugees successfully completed the 'Best Practices for Integrated Mosquito Management Virtual Training Programme', offered by the American Mosquito Control Association. These 17 refugees are determined to put these skills to work and perhaps start the very first mosquito abatement programme in Africa.
{"title":"What if professional mosquito abatement in Africa started in a refugee camp?","authors":"Silas Majambere","doi":"10.5281/zenodo.14278016","DOIUrl":"https://doi.org/10.5281/zenodo.14278016","url":null,"abstract":"<p><p>In the aftermath of the 2015 political crisis in Burundi, a humanitarian organisation, Maison Shalom, fled the country to Rwanda with tens of thousands of Burundians. In an attempt to assist their compatriots, a group of Burundians in the diaspora created the Académie <i>Ubuntu</i> and teamed with Maison Shalom to give online classes to the refugees. With courage and determination and despite the conditions in the refugee camp and the language barrier, 17 refugees successfully completed the 'Best Practices for Integrated Mosquito Management Virtual Training Programme', offered by the American Mosquito Control Association. These 17 refugees are determined to put these skills to work and perhaps start the very first mosquito abatement programme in Africa.</p>","PeriodicalId":74100,"journal":{"name":"MalariaWorld journal","volume":"15 ","pages":"14"},"PeriodicalIF":0.0,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11627122/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-22eCollection Date: 2024-01-01DOI: 10.5281/zenodo.13969756
Bart G J Knols
Overwhelmingly, contemporary malaria vector control equals the use of chemical pesticides (through insecticide-treated bednets or indoor residual spraying). Gradually, but surely, we have become enslaved to thinking that controlling malaria mosquitoes equals the use of chemical insecticides, and much of the vector control field today is dominated by scientists, lobbyists, chemical companies, funding agencies and (global) institutions that endlessly repeat this dogmatic belief. Although chemical control has undoubtedly saved millions of lives, which, morally speaking would immediately justify its continued use, it has many sides that may ultimately cost more lives than it saves. Not only the cyclical problems with insecticide resistance, but also our increased understanding of the human and environmental health impacts of these chemicals, continue to raise red flags. Furthermore, the millions of kilogrammes of annual bednet waste (polyethylene, polypropylene) and bednet packaging material cannot be ignored. In recent years, an abundance of evidence that the use of chemical pesticides is a prime cause for the global decline in insect biodiversity and abundance has surfaced. The rate at which this decline is happening is frightening and may sooner rather than later threaten food production on a global scale. Should we opt for saving lives in the short term by using chemicals and face devastating and irrevocable long-term consequences or become wise(r) in the way we control malaria mosquitoes?
{"title":"A shot in the foot: Could chemical control of malaria vectors threaten food security?","authors":"Bart G J Knols","doi":"10.5281/zenodo.13969756","DOIUrl":"10.5281/zenodo.13969756","url":null,"abstract":"<p><p>Overwhelmingly, contemporary malaria vector control equals the use of chemical pesticides (through insecticide-treated bednets or indoor residual spraying). Gradually, but surely, we have become enslaved to thinking that controlling malaria mosquitoes equals the use of chemical insecticides, and much of the vector control field today is dominated by scientists, lobbyists, chemical companies, funding agencies and (global) institutions that endlessly repeat this dogmatic belief. Although chemical control has undoubtedly saved millions of lives, which, morally speaking would immediately justify its continued use, it has many sides that may ultimately cost more lives than it saves. Not only the cyclical problems with insecticide resistance, but also our increased understanding of the human and environmental health impacts of these chemicals, continue to raise red flags. Furthermore, the millions of kilogrammes of annual bednet waste (polyethylene, polypropylene) and bednet packaging material cannot be ignored. In recent years, an abundance of evidence that the use of chemical pesticides is a prime cause for the global decline in insect biodiversity and abundance has surfaced. The rate at which this decline is happening is frightening and may sooner rather than later threaten food production on a global scale. Should we opt for saving lives in the short term by using chemicals and face devastating and irrevocable long-term consequences or become wise(r) in the way we control malaria mosquitoes?</p>","PeriodicalId":74100,"journal":{"name":"MalariaWorld journal","volume":"15 ","pages":"13"},"PeriodicalIF":0.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11502436/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-15eCollection Date: 2024-01-01DOI: 10.5281/zenodo.13934894
Anton Alexander
For many years, the malaria community appears to have stumbled and fumbled along in its effort to control malaria with varying results that have often been ineffective. This article makes the suggestion the malaria community has appeared to avoid studying or applying methods that are acknowledged to have been successful in Palestine 100 years ago. The article further suggests such avoidance arose due to an anti-semitic minority element in the Palestine Arab leadership in the 1920s and '30s which sought to inflame the general Palestine Arab populace against the Jews (who had initiated the malaria control) by dishonestly explaining the Arab woes in Palestine had been caused by the Jews. The article asks the question if today's anti-semitism has perpetuated the '20s and '30s Palestine anti-semitism and has thereby continued to discourage the malaria community today from openly adopting the successful anti-malaria methods employed in Palestine 100 years ago.
{"title":"Did antisemitism mislead and conceal from the world's malaria community the first start anywhere of a successful national malaria elimination campaign?","authors":"Anton Alexander","doi":"10.5281/zenodo.13934894","DOIUrl":"https://doi.org/10.5281/zenodo.13934894","url":null,"abstract":"<p><p>For many years, the malaria community appears to have stumbled and fumbled along in its effort to control malaria with varying results that have often been ineffective. This article makes the suggestion the malaria community has appeared to avoid studying or applying methods that are acknowledged to have been successful in Palestine 100 years ago. The article further suggests such avoidance arose due to an anti-semitic minority element in the Palestine Arab leadership in the 1920s and '30s which sought to inflame the general Palestine Arab populace against the Jews (who had initiated the malaria control) by dishonestly explaining the Arab woes in Palestine had been caused by the Jews. The article asks the question if today's anti-semitism has perpetuated the '20s and '30s Palestine anti-semitism and has thereby continued to discourage the malaria community today from openly adopting the successful anti-malaria methods employed in Palestine 100 years ago.</p>","PeriodicalId":74100,"journal":{"name":"MalariaWorld journal","volume":"15 ","pages":"12"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11537171/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142585259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-15eCollection Date: 2024-01-01DOI: 10.5281/zenodo.13934643
Ifeoma C Ezenyi, Kim Picozzi, John I Amaka, Obi P Adigwe
Background: Malaria is a leading cause of mortality in children aged 5 years and below in Nigeria. Treatment guidelines stipulate among other recommendations, testing by microscopy or a rapid diagnostic test (RDT) before treatment. Non-adherence to these guidelines portends a challenge, especially among vulnerable under-five children. This study explored the factors influencing Nigerian public health workers' (HWs) adherence to these guidelines in under-five children.
Methods: A review of literature published between 2011- 2023 was conducted on Web of Science, Ovid Embase, Medline, Global Health, CAB Abstracts, Scopus, and Global Index Medicus. Data was extracted and analyzed under 4 themes: diagnosis, compliance with test results, use of recommended treatment, post-treatment counselling and severe malaria management.
Results: Nineteen (19) studies were included for review. Training and supervision, RDT and antimalarial availability, good knowledge of, and positive perception of RDTs promoted adherence to mRDT use. A lack of confidence in RDTs and age (≥ 40 years) fuelled presumptive treatment, especially among clinicians. mRDT and artemisinin-based combination therapy (ACT) stockouts dissuaded HWs from adhering to case management guidelines. Caregiver pressure for treatment was identified as a barrier to compliance with test results.
Conclusions: It is important to design context-specific strategies to improve adherence to guidelines for malaria case management, especially in under-five children. Training on the guidelines should be tailored, needs-based, and continuous, and HWs should be supportively supervised in implementing case management. Maintaining an adequate supply of quality-assured mRDTs and antimalarials can facilitate adherence to the guidelines.
背景:疟疾是尼日利亚 5 岁及以下儿童死亡的主要原因。治疗指南规定,除其他建议外,在治疗前应通过显微镜或快速诊断检测(RDT)进行检测。不遵守这些指导原则是一项挑战,尤其是在脆弱的五岁以下儿童中。本研究探讨了影响尼日利亚公共卫生工作者(HWs)在五岁以下儿童中遵守这些指南的因素:在 Web of Science、Ovid Embase、Medline、Global Health、CAB Abstracts、Scopus 和 Global Index Medicus 上对 2011-2023 年间发表的文献进行了综述。数据提取和分析分为 4 个主题:诊断、检测结果依从性、推荐治疗的使用、治疗后咨询和重症疟疾管理:结果:19 项研究被纳入审查范围。培训和监督、RDT 和抗疟药物的供应、对 RDT 的充分了解和积极看法促进了对 mRDT 的使用。对快速检测试剂盒缺乏信心和年龄(≥ 40 岁)助长了推定治疗,尤其是在临床医生当中。护理人员施加的治疗压力被认为是妨碍他们遵守检测结果的一个因素:设计针对具体情况的策略以提高疟疾病例管理指南的依从性非常重要,尤其是在五岁以下儿童中。有关指南的培训应因地制宜、以需求为基础并持续进行,在实施病例管理的过程中应对保健人员进行支持性监督。保持充足的有质量保证的 mRDT 和抗疟药物的供应可促进对指导方针的遵守。
{"title":"Factors influencing health workers' adherence to malaria treatment guidelines in under-five children in Nigeria: A scoping review.","authors":"Ifeoma C Ezenyi, Kim Picozzi, John I Amaka, Obi P Adigwe","doi":"10.5281/zenodo.13934643","DOIUrl":"10.5281/zenodo.13934643","url":null,"abstract":"<p><strong>Background: </strong>Malaria is a leading cause of mortality in children aged 5 years and below in Nigeria. Treatment guidelines stipulate among other recommendations, testing by microscopy or a rapid diagnostic test (RDT) before treatment. Non-adherence to these guidelines portends a challenge, especially among vulnerable under-five children. This study explored the factors influencing Nigerian public health workers' (HWs) adherence to these guidelines in under-five children.</p><p><strong>Methods: </strong>A review of literature published between 2011- 2023 was conducted on Web of Science, Ovid Embase, Medline, Global Health, CAB Abstracts, Scopus, and Global Index Medicus. Data was extracted and analyzed under 4 themes: diagnosis, compliance with test results, use of recommended treatment, post-treatment counselling and severe malaria management.</p><p><strong>Results: </strong>Nineteen (19) studies were included for review. Training and supervision, RDT and antimalarial availability, good knowledge of, and positive perception of RDTs promoted adherence to mRDT use. A lack of confidence in RDTs and age (≥ 40 years) fuelled presumptive treatment, especially among clinicians. mRDT and artemisinin-based combination therapy (ACT) stockouts dissuaded HWs from adhering to case management guidelines. Caregiver pressure for treatment was identified as a barrier to compliance with test results.</p><p><strong>Conclusions: </strong>It is important to design context-specific strategies to improve adherence to guidelines for malaria case management, especially in under-five children. Training on the guidelines should be tailored, needs-based, and continuous, and HWs should be supportively supervised in implementing case management. Maintaining an adequate supply of quality-assured mRDTs and antimalarials can facilitate adherence to the guidelines.</p>","PeriodicalId":74100,"journal":{"name":"MalariaWorld journal","volume":"15 ","pages":"11"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11537172/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142585264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-02eCollection Date: 2024-01-01DOI: 10.5281/zenodo.13169433
Lee A Bulla
Introduction: The cadherin G-protein coupled receptor BT-R3 in the mosquito Anopheles gambiae is a single membrane-spanning α-helical (bitopic) protein that represents the most abundant and functionally diverse group of membrane proteins. Binding of the Cry4B toxin of Bacillus thuringiensis subsp. israelensis (Bti) to BT-R3 triggers a Mg2+-dependent signalling pathway in the mosquito that involves stimulation of G protein α-subunit, which subsequently launches a coordinated signalling cascade involving Na+/K+-ATPase. Described in this study is the behaviour of the Cry4B purified active protein toxin in solution relative to its protoxin predecessor produced by Bti as well as identification of the region within BT-R3 of An. gambiae to which the toxin binds.
Materials and methods: The relationship and behaviour of protoxin and toxin were ascertained in vitro by solubility studies in an alkaline environment like that of the mosquito larval midgut. To identify the specific toxin-binding site within BT-R3, the full-length coding sequence of the bt-r3 gene was amplified and cloned in pENTR/D-TOTO and subcloned in pXINSECT-DEST38 resulting in recombinant pXINSECT-DEST38-bt-r3. Cytotoxicity was analysed using Trichoplusia ni High Five™ insect cells transfected with the pXINSECT-DEST38-bt-r3 plasmid rendering them susceptible to the Cry4B toxin. Truncation mutational analyses, receptor-toxin binding studies and live cell experiments were used to elucidate the toxin-binding site in BT-R3.
Results: The N-terminal half of the Cry4B protoxin was cleaved releasing active Cry4B toxin. The nontoxic C-terminal portion was degraded into small peptide fragments. The receptor BT-R3 contained a single toxin-binding site--a 106-amino acid polypeptide bounded by Ile1359 and Ser1464 (1359IS1464) localized in the 11th cadherin repeat of the receptor.
Conclusions: The structural features of the toxin-binding site are critical to the specificity, selectivity and affinity of the active toxin and for the design and development of novel Bti-based biopesticides.
导言:冈比亚按蚊体内的粘着素 G 蛋白偶联受体 BT-R3 是一种单一的跨膜 α-螺旋(位点)蛋白,代表了最丰富、功能最多样化的膜蛋白群。苏云金芽孢杆菌以色列亚种(Bti)的 Cry4B 毒素与 BT-R3 结合后,会在蚊子体内触发 Mg2+ 依赖性信号途径,包括刺激 G 蛋白 α-亚基,随后启动一个涉及 Na+/K+-ATP 酶的协调信号级联。本研究描述了 Cry4B 纯化活性蛋白毒素在溶液中相对于其由 Bti 产生的前身原毒素的行为,并确定了冈比亚蚂 BT-R3 中毒素与之结合的区域:在体外,通过在碱性环境(如蚊子幼虫中肠)中的溶解度研究,确定了原毒素和毒素的关系和行为。为了确定 BT-R3 中的特异毒素结合位点,扩增了 bt-r3 基因的全长编码序列,并将其克隆到 pENTR/D-TOTO 中,然后亚克隆到 pXINSECT-DEST38 中,得到重组 pXINSECT-DEST38-bt-r3。使用转染了 pXINSECT-DEST38-bt-r3 质粒的 Trichoplusia ni High Five™ 昆虫细胞分析了细胞毒性,该质粒使细胞对 Cry4B 毒素敏感。截断突变分析、受体-毒素结合研究和活细胞实验用于阐明 BT-R3 中的毒素结合位点:结果:Cry4B 原毒素的 N 端半部分被裂解,释放出活性 Cry4B 毒素。无毒的 C 端部分被降解成小肽片段。受体BT-R3包含一个单一的毒素结合位点--一个106氨基酸的多肽,由Ile1359和Ser1464(1359IS1464)结合,位于受体的第11个干酪素重复序列中:毒素结合位点的结构特征对活性毒素的特异性、选择性和亲和性以及基于 Bti 的新型生物农药的设计和开发至关重要。
{"title":"Biochemical features of the Cry4B toxin of <i>Bacillus thuringiensis</i> subsp. <i>israelensis</i> and its interaction with BT-R<sub>3</sub>, a bitopic cadherin G-protein coupled receptor in <i>Anopheles gambiae</i>.","authors":"Lee A Bulla","doi":"10.5281/zenodo.13169433","DOIUrl":"10.5281/zenodo.13169433","url":null,"abstract":"<p><strong>Introduction: </strong>The cadherin G-protein coupled receptor BT-R<sub>3</sub> in the mosquito <i>Anopheles gambiae</i> is a single membrane-spanning α-helical (bitopic) protein that represents the most abundant and functionally diverse group of membrane proteins. Binding of the Cry4B toxin of <i>Bacillus thuringiensis</i> subsp. <i>israelensis</i> (Bti) to BT-R<sub>3</sub> triggers a Mg2+-dependent signalling pathway in the mosquito that involves stimulation of G protein α-subunit, which subsequently launches a coordinated signalling cascade involving Na<sup>+</sup>/K<sup>+</sup>-ATPase. Described in this study is the behaviour of the Cry4B purified active protein toxin in solution relative to its protoxin predecessor produced by Bti as well as identification of the region within BT-R<sub>3</sub> of <i>An. gambiae</i> to which the toxin binds.</p><p><strong>Materials and methods: </strong>The relationship and behaviour of protoxin and toxin were ascertained <i>in vitro</i> by solubility studies in an alkaline environment like that of the mosquito larval midgut. To identify the specific toxin-binding site within BT-R<sub>3</sub>, the full-length coding sequence of the <i>bt-r3</i> gene was amplified and cloned in pENTR/D-TOTO and subcloned in pXINSECT-DEST38 resulting in recombinant pXINSECT-DEST38-<i>bt-r3</i>. Cytotoxicity was analysed using <i>Trichoplusia ni</i> High Five™ insect cells transfected with the pXINSECT-DEST38-<i>bt-r3</i> plasmid rendering them susceptible to the Cry4B toxin. Truncation mutational analyses, receptor-toxin binding studies and live cell experiments were used to elucidate the toxin-binding site in BT-R<sub>3</sub>.</p><p><strong>Results: </strong>The N-terminal half of the Cry4B protoxin was cleaved releasing active Cry4B toxin. The nontoxic C-terminal portion was degraded into small peptide fragments. The receptor BT-R<sub>3</sub> contained a single toxin-binding site--a 106-amino acid polypeptide bounded by Ile1359 and Ser1464 (<sup>1359</sup>IS<sup>1464</sup>) localized in the 11th cadherin repeat of the receptor.</p><p><strong>Conclusions: </strong>The structural features of the toxin-binding site are critical to the specificity, selectivity and affinity of the active toxin and for the design and development of novel Bti-based biopesticides.</p>","PeriodicalId":74100,"journal":{"name":"MalariaWorld journal","volume":"15 ","pages":"10"},"PeriodicalIF":0.0,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11302571/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141899078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-07eCollection Date: 2024-01-01DOI: 10.5281/zenodo.11125657
Ezequias B Martins, Anielle de Pina-Costa, Roxana F Mamani, Otilia Lupi, Guilherme A Calvet, Clarisse S Bressan, Michele F B Silva, André M Siqueira, Sidnei da Silva, Graziela Maria Zanini, Maria de Fátima Ferreira-da-Cruz, Cláudio Tadeu Daniel-Ribeiro, Patrícia Brasil
Plasmodium vivax causes the vast majority of malaria cases in Brazil. The lifecycle of this parasite includes a latent stage in the liver, the hypnozoite. Reactivation of hypnozoites induces repeated relapses. We report a case of two relapses of vivax malaria in a teenage girl after conventional treatment with chloroquine and primaquine. Chloroquine prophylactic treatment for three months was prescribed with a favourable outcome of the case.
{"title":"Relapsing <i>Plasmodium vivax</i> malaria in a 12-year-old Brazilian girl: A case report.","authors":"Ezequias B Martins, Anielle de Pina-Costa, Roxana F Mamani, Otilia Lupi, Guilherme A Calvet, Clarisse S Bressan, Michele F B Silva, André M Siqueira, Sidnei da Silva, Graziela Maria Zanini, Maria de Fátima Ferreira-da-Cruz, Cláudio Tadeu Daniel-Ribeiro, Patrícia Brasil","doi":"10.5281/zenodo.11125657","DOIUrl":"10.5281/zenodo.11125657","url":null,"abstract":"<p><p><i>Plasmodium vivax</i> causes the vast majority of malaria cases in Brazil. The lifecycle of this parasite includes a latent stage in the liver, the hypnozoite. Reactivation of hypnozoites induces repeated relapses. We report a case of two relapses of <i>vivax</i> malaria in a teenage girl after conventional treatment with chloroquine and primaquine. Chloroquine prophylactic treatment for three months was prescribed with a favourable outcome of the case.</p>","PeriodicalId":74100,"journal":{"name":"MalariaWorld journal","volume":"15 ","pages":"8"},"PeriodicalIF":0.0,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11087666/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-23eCollection Date: 2024-01-01DOI: 10.5281/zenodo.11046816
Jacques D Charlwood
It is argued that reducing poverty is likely to alleviate malaria transmission and that the way to do this is by reducing inequality. The present capitalist system (as opposed to a straightforward market) tends to erode equality and promote profit over product. This may extend to the manufacture of bednets, bought by agencies rather than individual consumers, whose products may suffer from built in obsolescence. It is argued that better quality nets that can be re-impregnated locally are both desired and required. Derek Charlwood (aka Mzshensy#1) started his career as a medical entomologist in 1974 as a Research Assistant in the laboratory of the legendary Mick Gillies. By 2012 he had risen to become a Senior Research Assistant working for the Liverpool School of Tropical Medicine and so he is definitely ascending the career ladder. He has worked in numerous malaria endemic countries including Brazil, Papua New Guinea, Tanzania, Cambodia, São Tomé and Príncipe, Mozambique and Eritrea.
{"title":"Uneasy bedfellows: Public-Private partnerships for malaria control.","authors":"Jacques D Charlwood","doi":"10.5281/zenodo.11046816","DOIUrl":"10.5281/zenodo.11046816","url":null,"abstract":"<p><p>It is argued that reducing poverty is likely to alleviate malaria transmission and that the way to do this is by reducing inequality. The present capitalist system (as opposed to a straightforward market) tends to erode equality and promote profit over product. This may extend to the manufacture of bednets, bought by agencies rather than individual consumers, whose products may suffer from built in obsolescence. It is argued that better quality nets that can be re-impregnated locally are both desired and required. Derek Charlwood (aka Mzshensy#1) started his career as a medical entomologist in 1974 as a Research Assistant in the laboratory of the legendary Mick Gillies. By 2012 he had risen to become a Senior Research Assistant working for the Liverpool School of Tropical Medicine and so he is definitely ascending the career ladder. He has worked in numerous malaria endemic countries including Brazil, Papua New Guinea, Tanzania, Cambodia, São Tomé and Príncipe, Mozambique and Eritrea.</p>","PeriodicalId":74100,"journal":{"name":"MalariaWorld journal","volume":"15 ","pages":"9"},"PeriodicalIF":0.0,"publicationDate":"2024-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11070747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140860992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}